UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery and structure-activity relationships study of positive allosteric modulators of the M3 muscarinic acetylcholine receptor

Bioorganic & medicinal chemistry, 2020-07, Vol.28 (13), p.115531, Article 115531

2020

Volltextzugriff (PDF)

Cationic Platinum-Complex-Catalyzed Skeletal Reorganization of Enynes

Organometallics, 2001-08, Vol.20 (17), p.3704-3709

2001

Volltextzugriff (PDF)

Recent patenting activities in the discovery and development of vasopressin V 2 receptor agonists

Expert opinion on therapeutic patents, 2012-06, Vol.22 (6), p.579-586

Tsukamoto, Issei

2012

Volltextzugriff (PDF)

Recent patenting activities in the discovery and development of vasopressin V2 receptor agonists

Expert opinion on therapeutic patents, 2012-06, Vol.22 (6), p.579-586

Tsukamoto, Issei

2012

Volltextzugriff (PDF)

Discovery and structure-activity relationships study of positive allosteric modulators of the M 3 muscarinic acetylcholine receptor

Bioorganic & medicinal chemistry, 2020-07, Vol.28 (13), p.115531

2020

Volltextzugriff (PDF)

Expression and functional analysis of citrus carotene hydroxylases: unravelling the xanthophyll biosynthesis in citrus fruits

BMC plant biology, 2016-06, Vol.16 (1), p.148-148, Article 148

2016

Volltextzugriff (PDF)

Synthesis and structure–activity relationships of 6-{4-[(3-fluorobenzyl)oxy]phenoxy}nicotinamide derivatives as a novel class of NCX inhibitors: a QSAR study

Bioorganic & medicinal chemistry, 2005-02, Vol.13 (3), p.717-724

2005

Volltextzugriff (PDF)

Meeting Today's Innovation Challenges with New Approaches to Partnership

Pharmaceutical Executive, 2023-01, Vol.43 (1), p.7-7

Tsukamoto, Issei

2023

Volltextzugriff (PDF)

Synthesis and structure-activity relationships of amide derivatives of (4,4-difluoro-1,2,3,4-tetrahydro-5Η-1-benzazepin-5-ylidene)acetic acid as selective arginine vasopressin V2 receptor agonists

Bioorganic & medicinal chemistry, 2009-04, Vol.17 (8), p.3130-3141

2009

Volltextzugriff (PDF)

Synthesis and structure–activity relationships of amide derivatives of (4,4-difluoro-1,2,3,4-tetrahydro-5 H-1-benzazepin-5-ylidene)acetic acid as selective arginine vasopressin V 2 receptor agonists

Bioorganic & medicinal chemistry, 2009-04, Vol.17 (8), p.3130-3141

2009

Volltextzugriff (PDF)

Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene) acetamide derivatives as novel arginine vasopressin V2 receptor agonists

Bioorganic & medicinal chemistry, 2008-11, Vol.16 (21), p.9524-9535

2008

Volltextzugriff (PDF)

Optimization of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine-5-ylidene) acetamide derivatives as arginine vasopressin V2 receptor agonists and discussion of their binding modes

Bioorganic & medicinal chemistry, 2009-12, Vol.17 (24), p.8161-8167

2009

Volltextzugriff (PDF)

Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetamide derivatives as novel arginine vasopressin V(2) receptor agonists

Bioorganic & medicinal chemistry, 2008-11, Vol.16 (21), p.9524-9535

2008

Volltextzugriff (PDF)

Optimization of (4,4-difluoro-1,2,3,4-tetrahydro-5 H-1-benzazepine-5-ylidene)acetamide derivatives as arginine vasopressin V 2 receptor agonists and discussion of their binding modes

Bioorganic & medicinal chemistry, 2009-12, Vol.17 (24), p.8161-8167

2009

Volltextzugriff (PDF)

Optimization of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine-5-ylidene)ace tamide derivatives as arginine vasopressin V sub(2) receptor agonists and discussion of their binding modes

Bioorganic & medicinal chemistry, 2009-12, Vol.17 (24), p.8161-8167

2009

Volltextzugriff (PDF)

Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetami d e derivatives as novel arginine vasopressin V sub(2 receptor agonists)

Bioorganic & medicinal chemistry, 2008-11, Vol.16 (21), p.9524-9535

2008

Volltextzugriff (PDF)

Discovery of an N-(2-aminopyridin-4-ylmethyl)nicotinamide derivative: a potent and orally bioavailable NCX inhibitor

Bioorganic & medicinal chemistry, 2005-06, Vol.13 (12), p.4022-4036

2005

Volltextzugriff (PDF)

Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5 H-1-benzazepin-5-ylidene)acetamide derivatives as novel arginine vasopressin V 2 receptor agonists

Bioorganic & medicinal chemistry, 2008, Vol.16 (21), p.9524-9535

2008

Volltextzugriff (PDF)

Asymmetric Polyene Cyclization Via Episulfonium Ion

Phosphorus, sulfur, and silicon and the related elements, 1999-01, Vol.153 (1), p.311-312

1999

Volltextzugriff (PDF)

Meeting Today's Innovation Challenges with New Approaches to Partnership: The five key principles for effective collaboration in pharma

Pharmaceutical executive, 2023-01, Vol.43 (1), p.7

Tsukamoto, Issei

2023

Volltextzugriff (PDF)

ChemInform Abstract: Cationic Platinum-Complex-Catalyzed Skeletal Reorganization of Enynes

ChemInform, 2001-12, Vol.32 (50), p.no-no

2001

Volltextzugriff (PDF)

The effect of CT texture-based analysis using machine learning approaches on radiologists' performance in differentiating focal-type autoimmune pancreatitis and pancreatic duct carcinoma

Japanese journal of radiology, 2022-11, Vol.40 (11), p.1156-1165

2022

Volltextzugriff (PDF)

The protective effect and mechanism of COA-Cl in acute phase after spinal cord injury

Neuroscience research, 2021-09, Vol.170, p.114-121

2021

Volltextzugriff (PDF)

Ablation of C/EBP Homologous Protein Attenuates Endoplasmic Reticulum-Mediated Apoptosis and Cardiac Dysfunction Induced by Pressure Overload

Circulation (New York, N.Y.), 2010-07, Vol.122 (4), p.361-369

2010

Volltextzugriff (PDF)

Higd1a is a positive regulator of cytochrome c oxidase

Proceedings of the National Academy of Sciences - PNAS, 2015-02, Vol.112 (5), p.1553-1558

2015

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(63)
magazinearticle
(1)

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery and structure-activity relationships study of positive allosteric modulators of the M3 muscarinic acetylcholine receptor

Cationic Platinum-Complex-Catalyzed Skeletal Reorganization of Enynes

Recent patenting activities in the discovery and development of vasopressin V 2 receptor agonists

Recent patenting activities in the discovery and development of vasopressin V2 receptor agonists

Discovery and structure-activity relationships study of positive allosteric modulators of the M 3 muscarinic acetylcholine receptor

Expression and functional analysis of citrus carotene hydroxylases: unravelling the xanthophyll biosynthesis in citrus fruits

Synthesis and structure–activity relationships of 6-{4-[(3-fluorobenzyl)oxy]phenoxy}nicotinamide derivatives as a novel class of NCX inhibitors: a QSAR study

Meeting Today's Innovation Challenges with New Approaches to Partnership

Synthesis and structure-activity relationships of amide derivatives of (4,4-difluoro-1,2,3,4-tetrahydro-5Η-1-benzazepin-5-ylidene)acetic acid as selective arginine vasopressin V2 receptor agonists

Synthesis and structure–activity relationships of amide derivatives of (4,4-difluoro-1,2,3,4-tetrahydro-5 H-1-benzazepin-5-ylidene)acetic acid as selective arginine vasopressin V 2 receptor agonists

Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene) acetamide derivatives as novel arginine vasopressin V2 receptor agonists

Optimization of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine-5-ylidene) acetamide derivatives as arginine vasopressin V2 receptor agonists and discussion of their binding modes

Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetamide derivatives as novel arginine vasopressin V(2) receptor agonists

Optimization of (4,4-difluoro-1,2,3,4-tetrahydro-5 H-1-benzazepine-5-ylidene)acetamide derivatives as arginine vasopressin V 2 receptor agonists and discussion of their binding modes

Optimization of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine-5-ylidene)ace tamide derivatives as arginine vasopressin V sub(2) receptor agonists and discussion of their binding modes

Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetami d e derivatives as novel arginine vasopressin V sub(2 receptor agonists)

Discovery of an N-(2-aminopyridin-4-ylmethyl)nicotinamide derivative: a potent and orally bioavailable NCX inhibitor

Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5 H-1-benzazepin-5-ylidene)acetamide derivatives as novel arginine vasopressin V 2 receptor agonists

Asymmetric Polyene Cyclization Via Episulfonium Ion

Meeting Today's Innovation Challenges with New Approaches to Partnership: The five key principles for effective collaboration in pharma

ChemInform Abstract: Cationic Platinum-Complex-Catalyzed Skeletal Reorganization of Enynes

The effect of CT texture-based analysis using machine learning approaches on radiologists' performance in differentiating focal-type autoimmune pancreatitis and pancreatic duct carcinoma

The protective effect and mechanism of COA-Cl in acute phase after spinal cord injury

Ablation of C/EBP Homologous Protein Attenuates Endoplasmic Reticulum-Mediated Apoptosis and Cardiac Dysfunction Induced by Pressure Overload

Higd1a is a positive regulator of cytochrome c oxidase

Suchergebnisse filtern